Becton Dickinson, CareFusion receive US antitrust clearance
MLex Summary: Medical technology company Becton Dickinson and medical device maker CareFusion said that the US antitrust waiting period regarding their $12.2 billion deal expired on Nov. 19. The transaction remains subject...To view the full article, register now.
Already a subscriber? Click here to view full article